RESEARCH TRIANGLE PARK – CNBC’s MadMoney defends IBM stock against a downgrade, Cree is adding jobs, GSK expects a big year for drug approvals, plus news from LabCorp, Charlotte’s Capitala, Marken, Clarkston Consulting and Lumagenics.

Checou out these links:

• CNBC MadMoney questions IBM downgrade
• Cree adding workers in Wisconsin
• IBM joins Red Hat-launched patent group
• GSK CEO aims for six drug approvals in 2020
• Charlotte-based Capitala invests in wireless infrastructure firm
• LabCorp adds genetic tech from Thermo Fisher
• Cary-based Lumagenics names chief operating officer
• Clarkston Consulting promotes four executives
• Triangle-based Marken opens new center in Europe